Home › Research › Biomarkers
Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden
Hua M, Ma AJ, Liu ZQ, Ji LL, Zhang J, Xu YF, Chen WY, Mao LL.. Frontiers in aging neuroscience, 2023-07-14
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
Objective Arteriolosclerosis cerebral small vessel disease (CSVD) is a common type of CSVD. This study aimed to explore the factors associated with cognitive function and total MRI burden related to the disease. Methods The demographic characteristics, clinical manifestations, cognitive function score, Barthel Index (BI), blood test index, and follow-up results of arteriolosclerosis CSVD patients treated for the first time in our hospital from January 2014 to August 2022 were collected. White matter hyperintensity (WMH) Fazekas score, total MRI burden, and cerebral atrophy grade were evaluated according to brain MRI findings. Factors associated with CSVD cognitive function were analyzed by binary logistic regression. The correlative factors related to the total MRI burden of CSVD were analyzed by ordered multiple logistic regression. Results A total of 146 patients were included in this study, of which 132 cases (90.4%) had hypertension. There were 108 patients (74.0%) with cognitive dysfunction, 97 patients (66.4%) with balance and gait disorders, and 83 patients (56.8%) with moderate-to-severe dependence in daily life (BI ≤ 60 points). Of 146 patients, 79 (54.1%) completed clinical and imaging follow-ups for a median of 3 years. The number of patients with cognitive impairment and BI ≤ 60 points after follow-up significantly increased compared with the first admission ( P < 0.001). There were also significant differences in total MRI burden ( P = 0.001), WMH Fazekas score, and cerebral atrophy grade ( P < 0.001). Mean age ( P = 0.012), median deep WMH Fazekas score ( P = 0.028), and median deep ( P < 0.001) and superficial ( P =0.002) cerebral atrophy grade of patients with cognitive impairment at first admission were all higher than those with non-cognitive impairment. Multivariate analysis showed that deep cerebral atrophy was independently and significantly associated with cognitive impairment of CSVD ( P = 0.024), and hypertension was significantly and independently associated with total MRI burden ( P = 0.001). Conclusion The disease course of arteriolosclerosis CSVD may be related to cognitive function and total MRI burden. Deep cerebral atrophy was an independent risk factor for cognitive dysfunction in arteriolosclerosis CSVD, and hypertension was an independent risk factor for total MRI burden.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Hua, M., Ma, A. J., Liu, Z. Q., Ji, L. L., Zhang, J., Xu, Y. F., et al. (2023). Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden. Frontiers in aging neuroscience. https://doi.org/10.3389/fnagi.2023.1163349
Vancouver
Hua M, Ma AJ, Liu ZQ, Ji LL, Zhang J, Xu YF, et al. Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden. Frontiers in aging neuroscience. 2023. doi:10.3389/fnagi.2023.1163349. PMID: 37520130.
BibTeX
@article{hua2023-37520130,
author = {Hua, M. and Ma, A. J. and Liu, Z. Q. and Ji, L. L. and Zhang, J. and Xu, Y. F. and Chen, W. Y. and Mao, L. L.},
title = {{Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden}},
journal = {Frontiers in aging neuroscience},
year = {2023},
doi = {10.3389/fnagi.2023.1163349},
pmid = {37520130},
url = {https://doi.org/10.3389/fnagi.2023.1163349}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 8 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- This study aimed to explore the factors associated with cognitive function and total MRI burden related to the disease.
- Methods The demographic characteristics, clinical manifestations, cognitive function score, Barthel Index (BI), blood test index, and follow-up results of arteriolosclerosis CSVD patients treated for the first time in our hospital from January 2014 to August 2022 were collected.
- Factors associated with CSVD cognitive function were analyzed by binary logistic regression.
- Results A total of 146 patients were included in this study, of which 132 cases (90.4%) had hypertension.
- The number of patients with cognitive impairment and BI ≤ 60 points after follow-up significantly increased compared with the first admission ( P < 0.001).
New to this subject? Start with our plain-English guide: Blood tests & biomarkers →
Study details
- Participants146
- Effect size90.4%; 74.0%; 66.4%
- Evidence strengthLow
How this study scored 55/100
Published in a peer-reviewed journal. Scored zero for study design and randomized / blinded because the record does not state it. We have no data on journal's citation record, times cited, citations per year, impact for its field and year, cited by studies here, still being cited, senior author's track record, institution's track record and multicenter collaboration, so those were left out: it earned 32 of the 58 points we could judge it on, which is 55 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in aging neuroscience) |
| Journal's citation record | — / 4 | No journal record from OpenAlex — left out of this score |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 3 / 5 | 2023 — within 6 year(s) of the newest study here |
| Sample size | 2 / 4 | 146 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | — / 7 | No citation count (not found in OpenAlex) — left out of this score |
| Citations per year | — / 5 | No citation count or no year — left out of this score |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | — / 6 | Not yet checked against this library's citation graph — left out of this score |
| Still being cited | — / 4 | No yearly citation counts — left out of this score |
| Senior author's track record | — / 4 | Senior author's record not available — left out of this score |
| Institution's track record | — / 3 | No institution listed in OpenAlex — left out of this score |
| Multicenter collaboration | — / 3 | Institutions not listed — left out of this score |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 37520130) |
| Free to read | 2 / 2 | Free to read |
| Points | 32 / 58 | Scored on 11 of 20 parts. We have no data for the rest, so they are left out: 32 of the 58 points we could judge it on is 55 out of 100. |
| Total | 55 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Biomarkers from nearby years
Also tagged “burden”
4 studies in the library carry the topic tag “burden”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 4 tagged studies.